RxDoctor Payments Data

Peter Sculco, MD

Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1699001909

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $980,032 of the $1,462,871 with a category attached, or 67.0%. Zimmer Biomet accounts for 73.0% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $595,049, 7.9 times the $75,128 reported in 2019. Among adult reconstructive orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,462,871in general payments, 2019–2025

Across 631 payments — averaging $2318.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$1.1M
  • Encore Medical, LP$200K
  • Medical Device Business Services, Inc.$74K
  • Limacorporate S.p.a.$69K
  • Intellijoint Surgical Inc.$27K
  • Depuy Synthes Products, Inc.$6K
  • plus $20K from 10 others
$21,242in research payments, 2019–2025

Across 1 payment — averaging $21,242 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Heron Therapeutics, Inc.$21K
$132,315in ownership & investment interests, 2019–2025

Across 2 payments — averaging $66,157 each. An ownership or investment interest held by the physician or an immediate family member.

  • Intellijoint Surgical Inc.$132K
  • Insight Medical Systems, Inc.$0

What the payments were for

  • Consulting fees$980,03267%
  • Speaking & faculty fees$1,5000%
  • Travel & lodging$100,3067%
  • Food & beverage$17,2701%
  • Education$164,13111%
  • Gifts$1140%
  • Other$199,51714%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,462,871 in reported general payments places this provider in the 90th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$457,068
Medicare patients
536
Services billed
2,461

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefazolin Sodium17$683
Meloxicam17$59

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →